Sarep­ta rais­ing $325M; Astel­las joins the big mi­gra­tion to Cam­bridge, MA

→ With its shares boost­ed by news of swelling rev­enue from its eteplirsen fran­chise in Duchenne mus­cu­lar dy­s­tro­phy, Sarep­ta has priced shares $SRPT for a $325 mil­lion raise. The biotech says it plans to use the cash for a va­ri­ety of pur­pos­es, rang­ing from com­mer­cial­iza­tion ef­forts to busi­ness de­vel­op­ment and clin­i­cal tri­als.

→ Astel­las has joined the glob­al mi­gra­tion of bio­phar­ma com­pa­nies to Cam­bridge, MA. The Japan­ese phar­ma has tak­en a lease out on space in Cam­bridge, ac­cord­ing to a re­port from the Boston Busi­ness Jour­nal.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER